Now, cancer diagnosis in 15 minutes
Diagnosis of life-threatening diseases such as cancer may become a matter of minutes as scientists have developed a new bio-sensor technology, which they claim provides results within 15 minutes.
Diagnosis of life-threatening diseases such as cancer may become a matter of minutes as scientists have developed a new bio-sensor technology, which they claim provides results within 15 minutes.
A research team at the National Institute of Allergy and Infectious Diseases (NIAID) has developed a way to extract a portion of the surface of HIV that is recognisable to the antibody, known as an epitope, into a computer designed protein scaffold.
Dr Cyrus S Poonawalla, chairman and managing director of Serum Institute of India has become the first Indian to receive the Award for ‘Excellence in Inter-American Public Health’ by the Pan American Health Organisation (PAHO) and the Pan American Health and Education Foundation (PAHEF).
Anti-retroviral therapy (ART) is still inadequate in reaching people in India suffering from HIV-AIDS. Research says that 2.6 lakh people are still in dire need of ART in the country. According to the World Health Organisation’s (WHO) latest report, ‘Towards Universal Access,’ which tracks progress in achieving the 2010 target for HIV prevention, treatment and care, around 5.8 lakh HIV patients required ART in end-2009.
Canada ranked higher than the United States on all of the mortality measures except for mortality due to cancer, a criteria for which both countries earned a ‘B’ grade.
Some thirty seven national grid projects have teamed up, to set up a distributed computing network, that will enable laboratories to collaborate via thousands of computers merged into one supercomputer.
The Confederation of Indian Industry (CII) has recommended that bilateral economic cooperation be promoted through a focus on healthcare, information technology and entertainment sectors.
Government officials in the United Kingdom announced that they are scrapping a
A growing shortage of important chemotherapy drugs, anesthetics and antibiotics, which has compromised or delayed care for some US patients and may have led to at least 15 deaths, represents a “pressing public health problem.
CardioKinetix has raised $44m in Series E financing to progress the development of the Parachute ventricular partitioning device.
Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine fibroids associated with heavy menstrual bleeding.
The United Nations World Health Organisation (WHO) and its partners has recently called for increased research into patient safety, including the risks posed by care- and surgery-related infections, adverse drug effects and unsafe injections.
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. More than 9.5 million people worldwide die each year from infectious diseases. Of particular concern today are virulent forms of ‘super bugs’ that have mutated and grown resistant to available antibiotics.